findmyKOL
Clinical trialNCT01102218TerminatedPhase 2Interventional

A Safety Study of Pentoxifylline for the Treatment of Anemia

SponsorFresenius Medical Care North AmericaEnrollment48End Stage Renal Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Chronic kidney disease (CKD) patients have increased levels of inflammation and oxidative stress, which in turn contribute to anemia and cardiovascular disease. Pentoxifylline is known to have anti-inflammatory and anti-oxidant properties, and has shown promise in improving the treatment of patients with anemia. This study will examine the use of pentoxifylline for the treatment of anemia in chronic kidney disease.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Fresenius Medical Care North America

    Chicago, Illinois, United States

  • Fresenius Medical Care North America

    Kalamazoo, Michigan, United States

  • Fresenius Medical Care North America

    Brookhaven, Mississippi, United States

  • Fresenius Medical Care North America

    Tupelo, Mississippi, United States

  • Fresenius Medical Care North America

    City of Saint Peters, Missouri, United States

  • Fresenius Medical Care North America

    Saint Ann, Missouri, United States

  • Fresenius Medical Care North America

    Las Vegas, Nevada, United States

  • Fresenius Medical Care North America

    Columbia, Tennessee, United States

  • Fresenius Medical Care North America

    Irving, Texas, United States

  • Fresenius Medical Care North America

    Tyler, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epoetin alfa →Pentoxifylline →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2010
Primary completion
31 Jan 2012
Completion
31 Jan 2012
Last update posted
28 Mar 2012
Registered enrollment
48
Registry id
NCT01102218
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.